Interestingly, these cells were better attracted to TGF-β-expressing tumor cells, inhibited the differentiation of human naïve CD4+ T cells into Treg cells, and could inhibit tumor growth in vivo in a xenograft model of HCC. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.